InMed Pharmaceuticals Inc.

UBS Group AG INM
Report date
9/30/2026
Quarter
2026 Q3
Filed
11/10/2026
Shares
3,194
Value ($000)
4
Weight
0.0%
2024 Q4 - 2026 Q3 (6 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).